| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Molecular Targets, and Chemical Biology |
Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania
Requests for reprints: John G. Pastorino, Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Room 272, Jefferson Alumni Hall, Philadelphia, PA 19107. Phone: 215-503-5022; Fax: 215-923-2218; E-mail: John.Pastorino{at}jefferson.edu.
Transformed cells are highly glycolytic and overexpress hexokinase II (HXK II). HXK II is capable of binding to the mitochondria through an interaction with the voltage-dependent anion channel (VDAC), an abundant outer mitochondrial membrane protein. The binding of HXK II to mitochondria has been shown to protect against loss of cell viability. Akt activation inhibits apoptosis partly by promoting the binding of HXK II to the mitochondria, but the mechanism through which Akt accomplishes this has not been characterized. The present report shows that Akt mediates the binding of HXK II to the mitochondria by negatively regulating the activity of glycogen synthase kinase 3ß (GSK3ß). On inhibition of Akt, GSK3ß is activated and phosphorylates VDAC. HXK II is unable to bind VDAC phosphorylated by GSK3ß and dissociates from the mitochondria. Inhibition of Akt potentiates chemotherapy-induced cytotoxicity, an effect that is dependent on GSK3ß activation and its attendant ability to disrupt the binding of HXK II to the mitochondria. Moreover, agents that can force the detachment of HXK II from mitochondria in the absence of Akt inhibition or GSK3ß activation promoted a synergistic increase in cell killing when used in conjunction with chemotherapeutic drugs. Such findings indicate that interference with the binding of HXK II to mitochondria may be a practicable modality by which to potentiate the efficacy of conventional chemotherapeutic agents.
This article has been cited by other articles:
|
|
 |
|
  S. Abu-Hamad, H. Zaid, A. Israelson, E. Nahon, and V. Shoshan-Barmatz Hexokinase-I Protection against Apoptotic Cell Death Is Mediated via Interaction with the Voltage-dependent Anion Channel-1: MAPPING THE SITE OF BINDING J. Biol. Chem., May 9, 2008; 283(19): 13482 - 13490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Clarke, I. Khaliulin, M. Das, J. E. Parker, K. J. Heesom, and A. P. Halestrap Inhibition of Mitochondrial Permeability Transition Pore Opening by Ischemic Preconditioning Is Probably Mediated by Reduction of Oxidative Stress Rather Than Mitochondrial Protein Phosphorylation Circ. Res., May 9, 2008; 102(9): 1082 - 1090. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. JUHASZOVA, S. WANG, D. B. ZOROV, H. BRADLEY NUSS, M. GLEICHMANN, M. P. MATTSON, and S. J. SOLLOTT The Identity and Regulation of the Mitochondrial Permeability Transition Pore: Where the Known Meets the Unknown Ann. N.Y. Acad. Sci., March 1, 2008; 1123(1): 197 - 212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Sun, S. Shukair, T. J. Naik, F. Moazed, and H. Ardehali Glucose Phosphorylation and Mitochondrial Binding Are Required for the Protective Effects of Hexokinases I and II Mol. Cell. Biol., February 1, 2008; 28(3): 1007 - 1017. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. P. Shaik, E. K. Fifer, and G. Nowak Akt activation improves oxidative phosphorylation in renal proximal tubular cells following nephrotoxicant injury Am J Physiol Renal Physiol, February 1, 2008; 294(2): F423 - F432. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Zuurbier, P. J. M. Keijzers, A. Koeman, H. B. Van Wezel, and M. W. Hollmann Anesthesia's Effects on Plasma Glucose and Insulin and Cardiac Hexokinase at Similar Hemodynamics and Without Major Surgical Stress in Fed Rats Anesth. Analg., January 1, 2008; 106(1): 135 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Kim, J.-H. Yoon, J.-M. Jeong, G.-J. Cheon, T.-S. Lee, J.-I. Yang, S.-C. Park, and H.-S. Lee Apoptosis-inducing antitumor efficacy of hexokinase II inhibitor in hepatocellular carcinoma Mol. Cancer Ther., September 1, 2007; 6(9): 2554 - 2562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Y. Lee, S. J. Yu, Y. G. Park, J. Kim, and J. Sohn Glycogen Synthase Kinase 3{beta} Phosphorylates p21WAF1/CIP1 for Proteasomal Degradation after UV Irradiation Mol. Cell. Biol., April 15, 2007; 27(8): 3187 - 3198. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Patenaude, R. G. Deschesnes, J. L.C. Rousseau, E. Petitclerc, J. Lacroix, M.-F. Cote, and R. C.-Gaudreault New Soft Alkylating Agents with Enhanced Cytotoxicity against Cancer Cells Resistant to Chemotherapeutics and Hypoxia Cancer Res., March 1, 2007; 67(5): 2306 - 2316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Li, Y. Zhou, R. Wang, H. Zhang, Y. Dong, and C. Ip Selenium sensitizes MCF-7 breast cancer cells to doxorubicin-induced apoptosis through modulation of phospho-Akt and its downstream substrates Mol. Cancer Ther., March 1, 2007; 6(3): 1031 - 1038. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Huc, X. Tekpli, J. A. Holme, M. Rissel, A. Solhaug, C. Gardyn, G. Le Moigne, M. Gorria, M.-T. Dimanche-Boitrel, and D. Lagadic-Gossmann c-Jun NH2-Terminal Kinase-Related Na+/H+ Exchanger Isoform 1 Activation Controls Hexokinase II Expression in Benzo(a)Pyrene-Induced Apoptosis Cancer Res., February 15, 2007; 67(4): 1696 - 1705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Kroemer, L. Galluzzi, and C. Brenner Mitochondrial Membrane Permeabilization in Cell Death Physiol Rev, January 1, 2007; 87(1): 99 - 163. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
